Status:

UNKNOWN

The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg

Lead Sponsor:

Third Affiliated Hospital, Sun Yat-Sen University

Collaborating Sponsors:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions:

Chronic Hepatitis B

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

HBeAg-negative chronic hepatitis B (CHB) patients with low Level HBsAg were enrolled. After giving informed consent, patients were treated with nucleoside analog(s) (NAs) once a day and weekly subcuta...

Detailed Description

It is estimated that more than 400 million people are infected with hepatitis B virus (HBV) globally. HBeAg-negative CHB patients with low Level HBsAg were enrolled in the out-patient department of Th...

Eligibility Criteria

Inclusion

  • CHB patients who had received NAs for more than 12 months.
  • Hepatitis B e antigen (HBeAg)-negative.
  • Hepatitis B surface antigen (HBsAg) positive and \<1000 IU/mL.
  • Hepatitis B virus DNA \<100 IU/mL.

Exclusion

  • Patients with liver cirrhosis, Hepatocellular Carcinoma or alpha feto protein (AFP) \>2 upper limit of normal(ULN) or other malignancies.
  • Patients with other factors causing liver diseases.
  • Pregnant and lactating women.
  • Patients with concomitant HIV infection or congenital immune deficiency diseases.
  • Patients with diabetes, autoimmune diseases.
  • Patients with important organ dysfunctions.
  • Patients with serious complications (e.g., infection, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding.)
  • Patients who receive antineoplastic or immunomodulatory therapy in the past 12 months.
  • Patients who can't come back to clinic for follow-up on schedule.

Key Trial Info

Start Date :

January 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2020

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03801538

Start Date

January 1 2019

End Date

December 1 2020

Last Update

January 15 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China, 510630